These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36055575)

  • 1. The prevalence of cancer in patients with multiple sclerosis (MS) who received rituximab: a systematic review and meta-analysis.
    Mirmosayyeb O; Shaygannejad V; Ebrahimi N; Ghoshouni H; Ghajarzadeh M
    Neurologia (Engl Ed); 2022 Aug; ():. PubMed ID: 36055575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis.
    Moghadasi AN; Mirmosayyeb O; Barzegar M; Sahraian MA; Ghajarzadeh M
    Neurol Sci; 2021 Aug; 42(8):3093-3099. PubMed ID: 34100130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis.
    Mirmosayyeb O; Shaygannejad V; Bagherieh S; Hosseinabadi AM; Ghajarzadeh M
    Neurol Sci; 2022 Jan; 43(1):233-241. PubMed ID: 34787755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Seizure/Epilepsy in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis.
    Mirmosayyeb O; Shaygannejad V; Nehzat N; Mohammadi A; Ghajarzadeh M
    Int J Prev Med; 2021; 12():14. PubMed ID: 34084311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of cancer in multiple sclerosis (MS): A systematic review and meta-analysis.
    Ghajarzadeh M; Mohammadi A; Sahraian MA
    Autoimmun Rev; 2020 Oct; 19(10):102650. PubMed ID: 32801049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis.
    Mirmosayyeb O; Barzegar M; Nehzat N; Shaygannejad V; Sahraian MA; Ghajarzadeh M
    J Clin Neurosci; 2020 Sep; 79():33-38. PubMed ID: 33070914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prevalence of Cancer in Patients with Multiple Sclerosis (MS) who were Under Treatment with Natalizumab (Tysabri): A Systematic Review and Meta-Analysis.
    Nasirzadeh A; Jahanshahi R; Ghajarzadeh M; Mohammadi A; Sahraian MA; Moghadasi AN
    Int J Prev Med; 2023; 14():114. PubMed ID: 38264560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous posterior tibial nerve stimulation (PTNS) for lower urinary tract symptoms (LUTSs) treatment in patients with multiple sclerosis (MS): A systematic review and meta-analysis.
    Guitynavard F; Mirmosayyeb O; Razavi ERV; Hosseini M; Hosseinabadi AM; Ghajarzadeh M; Azadvari M
    Mult Scler Relat Disord; 2022 Feb; 58():103392. PubMed ID: 35216773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male Factor Infertility and Risk of Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis.
    Shahraki Z; Mohamadi A; Rastkar M; Ghajarzadeh M
    J Family Reprod Health; 2023 Dec; 17(4):194-198. PubMed ID: 38807619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
    Ma J; Yu H; Wang H; Zhang X; Feng K
    J Neuroimmunol; 2022 Feb; 363():577790. PubMed ID: 34959021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep brain stimulation for multiple sclerosis tremor: A systematic review and meta-analysis.
    Zali A; Khoshnood RJ; Motavaf M; Salimi A; Akhlaghdoust M; Safari S; Ghajarzadeh M; Mirmosayyeb O
    Mult Scler Relat Disord; 2021 Nov; 56():103256. PubMed ID: 34517191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) for a patient with relapsed mantle cell lymphoma who developed a human anti-chimeric antibody.
    Maeda T; Yamada Y; Tawara M; Yamasaki R; Yakata Y; Tsutsumi C; Onimaru Y; Kamihira S; Tomonaga M
    Int J Hematol; 2001 Jul; 74(1):70-5. PubMed ID: 11530808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Sexual Dysfunction in Women with Multiple Sclerosis: a Systematic Review and Meta-Analysis.
    Azimi A; Hanaei S; Sahraian MA; Mohammadifar M; Ramagopalan SV; Ghajarzadeh M
    Maedica (Bucur); 2019 Dec; 14(4):408-412. PubMed ID: 32153674
    [No Abstract]   [Full Text] [Related]  

  • 14. Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group.
    Tobinai K; Kobayashi Y; Narabayashi M; Ogura M; Kagami Y; Morishima Y; Ohtsu T; Igarashi T; Sasaki Y; Kinoshita T; Murate T
    Ann Oncol; 1998 May; 9(5):527-34. PubMed ID: 9653494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of rituximab in the treatment of neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
    Wang Y; Chang H; Zhang X; Yin L
    Mult Scler Relat Disord; 2021 May; 50():102843. PubMed ID: 33609924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of cognitive impairment (CI) in patients with multiple sclerosis (MS): A systematic review and meta-analysis.
    Askari M; Mirmosayyeb O; Fattahi F; Ghoshouni H; Moases Ghaffary E; Shaygannejad V; Ghajarzadeh M
    Caspian J Intern Med; 2024; 15(3):392-413. PubMed ID: 39011445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk of developing sexual dysfunction in women with multiple sclerosis (MS): a systematic review and meta-analysis.
    Yazdani A; Ebrahimi N; Mirmosayyeb O; Ghajarzadeh M
    BMC Womens Health; 2023 Jul; 23(1):352. PubMed ID: 37403051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of cancer in patients with multiple sclerosis (MS) who were treated with fingolimod: A systematic review and meta-analysis.
    Askari M; Mirmosayyeb O; Ghaffary EM; Ghoshouni H; Shaygannejad V; Ghajarzadeh M
    Mult Scler Relat Disord; 2022 Mar; 59():103680. PubMed ID: 35176641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Anti-JC Virus Antibody Seropositivity in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis.
    Hanaei S; Sahraian MA; Mohammadifar M; Ramagopalan SV; Ghajarzadeh M; Ghajarzadeh M
    Intervirology; 2019; 62(5-6):169-173. PubMed ID: 32623436
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.